Custom service
Protein Engineering Services
Stability, solubility, affinity and humanisation — the everyday engineering requests.
Most protein engineering requests are not exotic. A protein that aggregates at working concentration; an antibody that must be humanised for a therapeutic programme; an enzyme that loses activity above 40 °C; a construct that expresses but binds weakly. Each has a standard playbook, and the playbooks share one structure: identify the residues involved from structure and sequence analysis, design a small focused variant set, and measure.
Stability engineering looks for destabilising motifs — unsatisfied buried hydrogen bonds, exposed hydrophobics, strained loops — and tests conservative substitutions, disulfide introduction and consensus-sequence repairs. Solubility engineering targets aggregation-prone surface patches, charge reversal and aggregation-prone sequence motifs. Affinity engineering focuses interface residues with saturation or focused libraries. Humanisation grafts CDRs onto human frameworks with back-mutation at positions that structural analysis flags as packing-critical.
What distinguishes a serviceable result from a good one is measurement discipline. Variants are expressed under identical conditions, characterised by the same assays, and compared against the parent under the same parameters. The final variant is the best measured option, not the one with the most plausible rationale.
This service covers the engineering requests that arrive in the middle of a project: a protein that must survive an assay condition, an antibody heading toward a therapeutic context, an enzyme that needs ten more degrees.
It is not the tool for discovering a new activity, which needs directed evolution or design, and it cannot fix a protein whose fold is fundamentally incompatible with the required condition.
Every variant is reported with expression yield, purity, target-property measurement and collateral checks on stability and activity. The selected variant is compared against the parent in the same analytical run, and all intermediate variants are archived with their data.
Service Highlights
- Structure-led variant design. Mutations proposed from structure and sequence analysis, 5–30 variants per objective rather than a shotgun library.
- Consensus and back-mutation analysis. Family alignments identify positions where the consensus repairs a destabilising choice.
- Humanisation with packing analysis. CDR grafting onto the closest human framework, with back-mutations decided by structural modelling rather than by rule of thumb.
- Disulfide engineering. Engineered disulfides introduced only where geometry and dynamics support them, and verified by folding behaviour.
- Measured comparison. Every variant expressed and assayed identically, with the parent run in the same batch.
- Multi-objective option. Stability and activity weighted together when a stability mutation would cost function.
How the work runs
Objective definition
The property, its current value and its target value specified with the assay that will measure the change.
Structural and sequence analysis
Structure obtained or predicted; family alignment and aggregation prediction run to locate candidate positions.
Variant design
5–30 variants designed and rationalised, each with a predicted effect and a reason to include it.
Expression and purification
Variants expressed under identical conditions and purified to comparable purity.
Characterisation
The target property measured on every variant alongside the parent, with stability and activity checked for collateral damage.
Selection and delivery
The best variant delivered purified, with the full comparison dataset and rationale.
Specifications & timeline
- Objectives
- Thermal stability, solubility, aggregation resistance, affinity, humanisation, truncation, tag-free variants
- Variant scale
- 5–30 per objective
- Methods
- Structural modelling, consensus analysis, site-directed mutagenesis, disulfide design
- Assays
- nanoDSF/DSF, SEC-MALS, activity, SPR/BLI, solubility
- Timeline
- 4–10 weeks per objective
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.